biotechnology

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…

Worcester Polytechnic Institute (WPI) researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the…

WASHINGTON — President Trump heralded his signature drug discount platform, TrumpRx, as “one of the most transformative health…

Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…

NEW YORK – February 25, 2026 Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage…

WASHINGTON — Tracy Beth Høeg, the top drug regulator at the Food and Drug Administration, indicated in her…

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…

Colombian chemist Ronald Ríos co-leads Nature study on vitamin B12 as bacterial UV light sensor. Ronald Ríos Santacruz,…

Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand…

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…

Engineered lettuce may turn injectable GLP-1 therapies into oral pills